Edwards Lifesciences (EW) Pre-announces Disappointing Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Canaccord Genuity Defends Edwards Lifesciences (EW)
October 9, 2012 10:55 AM EDTCanaccord Genuity maintained a Buy on Edwards Lifesciences (NYSE: EW) but cut its price target to $109.00 (from $123.00).
Yesterday after the close, Edwards Lifesciences reported revenue that disappointed the street and transcatheter heart valve sales that were below expectations.
... More
RBC Capital Downgrades Edwards Lifesciences (EW) to Outperform after Warning
October 9, 2012 6:54 AM EDTRBC Capital downgraded Edwards Lifesciences (NYSE: EW) from Top Pick to Outperform with a price target of $102.00 (from $105.00) after last night's third quarter warning.
... More
Edwards Lifesciences (EW) Rivals on Watch after Q3 Warning
October 8, 2012 5:26 PM EDTA number of rivals to Edwards Lifesciences Corp. (NYSE: EW) are on watch after-hours Monday after the company warned for the third quarter.
Edwards Lifesciences estimates total sales of $448 million for the quarter ended September 30, 2012. The consensus revenue estimates was for $476.56 million.... More
